 ENGLEWOOD, Colo., July 27, 2021 PRNewswire -- Ampio Pharmaceuticals NYSE American: AMPE, a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced details on the Companys poster presentation, Inflammation and COVID Induced ARDS: Inhaled AmpionTM as a Therapeutic Option, being given at the 63rd annual Thomas L. 